Carlsbad, CA, Sept. 11, 2023 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, today announced the appointment of Mitchell Jones, M.D., Ph.D., as Chief Medical Officer. Dr. Jones has a proven track record of…Read More
Palisade Bio Appoints GI Clinical Expert and Biotech Entrepreneur Mitchell Jones MD PhD as Chief Medical Officer
